Revvity to Present at Goldman Sachs Global Healthcare Conference

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY) will present at the 45th Annual Goldman Sachs Global Healthcare Conference on Monday, June 10, 2024 at 8:00 a.m. ET in Miami, FL.

Prahlad Singh, president and chief executive officer, will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website at www.revvity.com. A replay of the presentation will be posted on the Revvity Investor Relations website after the event and will be available for at least 30 days.

About Revvity

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240528846410/en/

Investor Relations:
Steve Willoughby
[email protected]

Media Relations:
Chet Murray
(781) 663-5719
[email protected]

Source: Revvity

You May Also Be Interested In

• Patent Partner Robert Fergan Joins Dorsey in Chicago
• adapfin to Build a Banking Product Live in Under Seven Minutes at Finovate Fall 2026
• Subscribr Launches AI Platform to Ideate, Script and Edit a Month of YouTube Videos in a Day